Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Ameren (AEE)

NYSE: AEE · Multi-Utilities · St Louis, MO

Our rating: Neutral

Neutral reaffirmed at $114.02, moderate conviction, November 9, 2026.

Breaks if: The Neutral call turns Positive if Ameren reports diluted EPS of $5.80 or above on the next full-year print — roughly 8-9% growth from the current $5.35 — confirming that rate-base compounding is running faster than a 21x multiple already implies. It turns Cautious if EPS falls below $5.00 on the next annual report, or if a rate case decision from its primary state regulators produces an allowed ROE below 9.5% within the next 12 months, signaling that the regulatory compact is tightening and the premium multiple becomes harder to defend.

Key figures

Market value$31.0B
Revenue, last 12 months$8.7B
Net income, last 12 months$1.6B
Free cash flow, last 12 months−$1.4B
Price to earnings19.8×
Free cash flow yield−4.5%
Dividend yield2.6%
Operating margin24.9%
Return on equity12.1%
Beta to the S&P 5000.11
Volatility, annualized17.6%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
June 30, 2026$2.1B−5.8%$1.13−$309M
March 31, 2026$2.2B3.8%$1.28−$1.2B
December 31, 2025$1.8B−8.2%$0.92−$54M
September 30, 2025$2.7B24.2%$2.35$116M
June 30, 2025$2.2B31.2%$1.01−$204M
March 31, 2025$2.1B15.5%$1.07−$633M
December 31, 2024$1.9B20.0%$0.77−$473M
September 30, 2024$2.2B5.5%$1.70−$240M

9 ledger entries and 31 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.